Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: XORTX Therapeutics(XRTX) the EBIT is -392.35 K (+43.17%);the EPS is -1.05 (-10.53%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B43.17%
----
----
EPS
-1.0510.53%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf